ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-Remitting Multiple Sclerosis

This study has been terminated.
Information provided by Bristol-Myers Squibb
Please refer to this study by its ClinicalTrials.gov identifier: NCT00035529


Locations
United States, Connecticut
Local Institution    
      New Haven, Connecticut, United States
United States, Kentucky
Local Institution    
      Louisville, Kentucky, United States
United States, Massachusetts
Local Institution    
      Worcester, Massachusetts, United States
United States, New Jersey
Local Institution    
      Newark, New Jersey, United States
United States, New York
Local Institution    
      New York, New York, United States
United States, North Carolina
Local Institution    
      Charlotte, North Carolina, United States
United States, Pennsylvania
Local Institution    
      Philadelphia, Pennsylvania, United States
United States, Texas
Local Institution    
      Dallas, Texas, United States
United States, Vermont
Local Institution    
      Burlington, Vermont, United States
United States, Wisconsin
Local Institution    
      Madison, Wisconsin, United States

Sponsors and Collaborators
Bristol-Myers Squibb





Links to all studies - primarily for crawlers